Management ChangeApr 6, 2026, 04:16 PM
Skye Bioscience Corrects Option Repricing Error: 2,458,158 Shares Underlying Repriced Options
AI Summary
Skye Bioscience filed an amendment to its previous 8-K report to correct a scrivener's error regarding the total number of shares underlying repriced options. The corrected number is 2,458,158 shares. While a correction, the repricing of options can be a material event for investors as it impacts potential dilution and executive compensation.
Key Highlights
- Skye Bioscience filed an 8-K/A to correct an error in the original 8-K filed on April 3, 2026.
- The error concerned the total number of shares of common stock underlying all Repriced Options.
- The corrected number of shares underlying all Repriced Options is 2,458,158.
Price Impact
More from SKYE